LPSs are key factors in the activation of the immune response through TLR4 signaling, contributing to inflammation, and loss of intestinal permeability seen in CeD (Levy et al., 2017; Salguero et al., 2019). This evidence concerns the gene TLR4 and cranioectodermal dysplasia.